FDA Warning Letter — Revibe LLC
The FDA took a Warning Letter action against Revibe LLC on May 18, 2018 (Kansas City, MO). The action was issued by CDER and concerns drugs products.
Action Details
- Facility
- Revibe LLC
- Date
- May 18, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Center
- CDER
- Location
- Kansas City, MO (United States)